Examining the legal frameworks for new analogues
Demystifying the PMTA Pathway for Nicotine Pouches: Key Challenges and Opportunities
The U.S. Food and Drug Administration (FDA) has set out a rigorous regulatory framework for nicotine-containing products, with the Premarket Tobacco Product Application (PMTA) pathway being a critical requirement for market access. For nicotine...
Results - 86 Blogs
On January 16, 2025, the FDA granted marketing authorisation for Swedish Match’s Zyn nicotine...
The Keller and Heckman LLP E-Vapor and Tobacco Law Symposium provided in-depth discussions on the...
Nicotine pouches are exciting products that can help support worldwide tobacco harm reduction....
As the global tobacco and nicotine market evolves, nicotine pouches are emerging as a popular...
Broughton welcomes the US Food and Drug Administration’s (FDA) decision to authorize ZYN nicotine...
Navigating FDA and ICH Guidelines: Analytical Testing Validation for Tobacco Products
Oral nicotine pouches have become a disruptive force in the reduced-risk nicotine product...
Allergies concerns highlights need to meet stringent regulations ~
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
